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genetic factors in disease occurrence.
XPD encodes a helicase, which participates in both nucleoThe XPD gene product has a dual function in basal tide excision repair and basal transcription as part of the transcription and in nucleotide excision repair. We have transcription factor TFIIH (7). Mutations destroying enzymatic previously reported that two polymorphisms in the gene, function of the XPD protein is manifested clinically in comone silent mutation in codon 156 of exon 6 and one giving binations of three severe syndromes, Cockayne syndrome, rise to a Lys→Gln substitution in codon 751 of exon 23, xeroderma pigmentosum and trichotiodystrophy depending on showed signs of being associated with basal cell carcinoma the location of the mutation (8, 9) . In healthy individuals, the in a Scandinavian study group of psoriasis patients and non-XPD protein level may also be of importance as the mRNA psoriatics with and without basal cell carcinoma [Dybdahl, level of XPD has been shown to correlate with the DNA repair Vogel, Frentz, Wallin and Nexø (1999) Cancer Epidemiol.
capacity in primary lymphoblasts (10) .
Biomark. Prev., 8, 77-81]. In both polymorphisms, the CC
We have previously presented data to suggest that two genotype appeared to be protective against basal cell known polymorphisms in the nucleotide excision repair gene carcinoma. Here, we have genotyped an American study XPD were associated with increased risk of basal cell carcinoma group of basal cell carcinoma patients and controls without (BCC) amongst Scandinavian psoriasis patients, who through skin cancer for the two polymorphisms. In addition, we their treatment for psoriasis were exposed to very genotoxic studied an A→G polymorphism in codon 312 of exon 10, agents such as coal tar, psoralen and UV light, X-rays and which results in an Asp→Asn substitution in a conserved methotrexate. For the polymorphism in exon 23, an association region of XPD. In the whole study group, subjects carrying to BCC was suggested among psoriatics as well as nonthe AA and AC genotype in exon 6 were at 1.9-fold higher psoriatics (OR ϭ 4.3, P ϭ 0.075), whereas for the exon 6 risk of basal cell carcinoma (P ⍧ 0.062, CI 0.96-3.75). If polymorphism an association was only suggested in psoriatics only subjects without a family history of non-melanoma (OR ϭ 5.3, P ϭ 0.078) (11) . Subjects carrying AA genotype skin cancer were included, subjects carrying AA or AC were in both cases at higher risk of BCC. In addition, we have genotype were at 3.3-fold higher risk of basal cell carcinoma included a G→A polymorphism in codon 312 of exon 10 (P ⍧ 0.007, CI 1.35-8.18). Among subjects with a family which results in an Asp→Asn substitution in an evolutionally history of non-melanoma skin cancer, subjects with an AG conserved region (12) (13) (14) . or AA genotype in codon 312 of exon 10 were at 5.25-fold
In the present study, we have analyzed three XPD polyincreased risk of basal cell carcinoma (P ⍧ 0.027, CI morphisms in a well-described study group of American BCC 1.15-23.93). A protective effect of the CC genotype in exon patients and controls recruited at dermatological clinics (4).
could not be confirmed. Cases with a family history of
We confirm that the XPD exon 6 CC genotype is protective skin cancer had statistically significantly different allele against basal cell carcinoma. This protective influence mainly frequencies of the polymorphisms in exon 6 and exon 10 occurs among persons without a family history of nonfrom cases without family history of non-melanoma skin melanoma skin cancer. Among subjects with a family history cancer. Our results indicate that the exon 6 A allele is a risk of non-melanoma skin cancer, the A-allele of the exon 10 factor in basal cell carcinoma.
polymorphism was associated with increased risk of BCC.
Materials and methods Introduction

Study subjects
Genes involved in DNA repair play a critical role in the first Details of the study population and subject selection have been described line of defense against cancer. This is illustrated by the rare previously (4). Briefly, the study was a clinic based case-control study at the hereditary disease xeroderma pigmentosum (1), which results Johns Hopkin's Hospital, which serves multiple participating dermatologists in more than a 1000-fold increased risk of sunlight induced in Maryland. Cases were histopathologically confirmed primary BCCs and skin cancer, caused by defects in the nucleotide excision repair were diagnosed between 1987-1990. The controls were patients from the same physician practices and had a diagnosis of mild skin disorders. All pathway. Another example is the relationship between defects participants were Caucasians living near Baltimore and were between 20 and in mismatch repair genes and familial colon cancer (2). 60 years of age. The controls were frequency matched to the cases by age and sex. Cases and controls with any other form of cancer were excluded. In the questionnaire, the study subjects were asked if they had any blood relatives Abbreviations: BCC, basal cell carcinoma; OR, odds ratio; CI, confidence interval.
with skin cancer, and were asked to specify the type of cancer. Study subjects with relatives with basal cell carcinoma and squamous cell carcinoma and 'skin cancer' were included in the group of subjects with a family of skin c Lifetime number of severe sunburns. and 5 µl genomic DNA. The cycling conditions were initial denaturation at 96°C for 60 s, followed by 30 cycles of 30 s at 94°C, 30 s at 60°C and 72°C for 60 s. The second PCR reaction was performed as described previously
Results
using 0.25-1 µl PCR reaction 1.
Exon 6
We have performed a study of BCC in relation to XPD gene polymorphisms in patients with BCC and in controls without
In the first PCR reaction, the primers 5Ј-CAC ACC TGG CTC ATT TTT GTA T-3Ј and 5Ј-TCA TCC AGG TTG TAG ATG CCA-3Ј were used. PCR BCC recruited in America. The study group is described in reactions were performed in a 25 µl volume containing 10 mM Tris-HCl detail elsewhere (4). Table I summarizes the distribution of pH 8.9, 50 mM KCl, 1 mM MgCl 2 and 5 µl genomic DNA. The cycling age and gender for this population. We have analyzed three conditions were initial denaturation at 96°C for 60 s, followed by 30 cycles previously described polymorphisms (6-8,14), two giving rise of 30 s at 94°C, 30 s at 58°C and 72°C for 60 s. The second PCR reaction was performed as described previously using 0.25-1 µl PCR reaction 1.
to non-conservative amino acid substitutions in codons 312 and 751, and one silent nucleotide substitution in codon 156.
Restriction enzyme analysis
The distribution of the genotypes in the study groups is shown Restriction enzyme analysis was performed as described previously (11) . In in Table II. exon 6, the A-but not the C-allele has a TfiI restriction site within the 652 bp amplified PCR product. In addition, there is a second TfiI restriction site
Exon 6, codon 156
within the amplified fragment that serves as an internal control for digestion.
The C→A polymorphism in exon 6 at nucleotide 22541 does frequency of the A-allele in the whole cohort was 0.44, In exon 23, the C-but not the A-allele has a PstI restriction site within the which is in agreement with previous reports (11, (14) (15) (16) ). The 324 bp PCR product. In addition, there is a second PstI restriction site within distribution of the genotypes in the control group was in the amplified fragment that serves as an internal control for digestion. The three possible genotypes are defined by three distinct banding patterns: CC Hardy-Weinberg equilibrium. When the whole study group (66, 100 and 158 bp fragments), CA (66, 100, 158 and 224 bp fragments) and was considered, the CC genotype was mildly protective against AA (100 and 224 bp fragments).
basal cell carcinoma. Subjects carrying an AC genotype were Exon 10 at an~2-fold increased risk of BCC (P ϭ 0.056, CI 0.98-The exon 10 polymorphism (A23591G) was typed using a Lightcycler™ 4.13) (Table II) . However, when only subjects with no family (Roche, Switzerland) to amplify the genomic DNA in a real-time PCR reaction history of basal cell carcinoma were included (Table III) , the and then determine the temperature profile of the fluorescent energy-transfer C-allele was protective against BCC. Thus, subjects carrying between an anchor and a sensor probe. The primers and probes were AC or AA genotypes were at 3.3-fold increased risk of BCC as follows: forward primer, 5Ј-GATCAAAGAGACAGACGAGC-3Ј; reverse (P ϭ 0.007, CI ϭ 1.35-8.18).
primer, 5Ј-GAAGCCCAGGAAATGC-3Ј; anchor probe, 5Ј-CGCAGTAC-CAGCATGACACCAGCCT-Fluorescein-3Ј; sensor probe, 5Ј-LCRed640-CCThe DNA repair capacity has previously been measured in CCACTGCC-GATTCTATGAGG-p-3Ј. The reaction mix contained 500 nM this study group (4). In the whole study group, subjects with each primer, 200 nM anchor and sensor probes, 10% DNA Master Hybridizaa CC genotype had on average a slightly higher DNA repair tion Probes mix (Roche) which contains DNA polymerase, dNTP and buffer capacity (7.83% cat activity at 700 J/m 2 ) than subjects carrying (3.5 mM MgCl 2 and 5% DMSO). After an initial denaturation of 2 min at 95°C, the regimen consisted of 45 cycles of 10 s at 95°C, 15 s at 53°C and an AC (7.76%) or AA (7.46%) genotype, although the difference 30 s at 72°C. The last cycle was extended by 2 min at 72°C for polishing.
was not statistically significant. This tendency was enhanced To read the temperature profile of the energy transfer the PCR products were among subjects without a family history of skin cancer, as denatured for 10 s at 95°C, cooled to 50°C for 30 s and subjected to a subjects with a CC genotype had an average DNA repair temperature ramp from 50 to 95°C with a slope of 0.1°C/s. The difference in capacity of 7.99% cat activity at 700 J/m 2 , whereas subjects melting temperature between the allele having a perfect match with the sensor (the A-allele) and the allele with 1 base mismatch (the G-allele) was 8°C.
carrying an AC had on the average 7.65% and subjects carrying AA genotype had an average activity of 7.39% at 700 J/m 2 .
Statistical methods
None of the differences were statistically significant. Among Data analysis and χ 2 tests were performed using Excel (Microsoft). Odds ratios and confidence intervals were calculated manually.
subjects with a family history of BCC, there was no association between exon 6 polymorphism and cancer status (Table III) . The distribution of the genotypes in the control group was in Hardy-Weinberg equilibrium. There was no difference in In a previous Scandinavian study (11) , it was found that the C-allele was protective against BCC among psoriasis patients DNA repair capacity between the different genotypes (data not shown). When the whole study group was considered, (P ϭ 0.078), but not among non-psoriatic patients. Exclusion of subjects with a family history of non-melanoma skin there was no difference in allele frequencies among BCC cases and controls (Table II) . However, among subjects with cancer from the Scandinavian study group (including both psoriatics and non-psoriatics) increased the protective effect a family history of BCC, subjects carrying AG or AA genotypes were at 5.25-fold increased risk of BCC (P ϭ 0.027, of the C-allele in the Scandinavian study group, although the protection was not statistically significant (results not shown).
CI ϭ 1.15-23.93) (Table IV) . Among subjects without family history of non-melanoma skin cancer, there was no difference Exon 10, codon 312 in genotype distribution between BCC cases and controls. The G→A polymorphism in codon 312 of exon 10 results
Exon 23, codon 751 in an Asp→Asn substitution in an evolutionally conserved region (12, 13) . The average frequency of the C-allele was
The A→C polymorphism in exon 23 at nucleotide position 35931 gives rise to the amino acid substitution Lys→Gln in 0.38, which is in agreement with previous findings (13,14) . codon 751. The average frequency of the C-allele was 0.39, The association of a family history of non-melanoma skin cancer with the allele frequency is listed in Table VI . The Awhich is at the high end of the previously reported allele frequencies (0.29-0.40) (11, (13) (14) (15) . The distribution of the allele frequency in exon 6 among BCC cases with a family history of non-melanoma skin cancer is lower than the A-allele genotypes in the control group was in Hardy-Weinberg equilibrium. When the whole group was considered, there was frequency among BCC cases without a family history of nonmelanoma skin cancer (P ϭ 0.013). Likewise, the allele no correlation between genotype and risk of basal cell cancer, as the allele frequency was almost identical in the two groups frequency of the A-allele in exon 10 is higher among BCC cases with a family history of non-melanoma skin cancer than (Table II) . However, when only subjects with a family history of BCC were considered, the A-allele was mildly protective among subjects without family history of non-melanoma skin cancer (P ϭ 0.042). (Table V) . Thus, subjects carrying an AC or CC genotype had a 3.6-fold increased risk of BCC (P ϭ 0.092, CI 0.78-17.00).
We have previously found that the polymorphisms in exons 6 and 23 of the XPD gene are closely linked in a Scandinavian This is opposite of the tendency in the Scandinavian study group of psoriasis patients, where it was found that the C-allele study group (11) . The two polymorphisms are also closely linked in this study group with a P value of 2ϫ10 -12 . was mildly protective (11) . There was no statistically significant difference in DNA repair capacity between the different
The present study group is more heterogeneous than the Scandinavian study group as the haplotype exon 6 A exon 23 C genotypes.
was not found in the Scandinavian study group, but was of sunburns. Other studies have also identified the number of lifetime sunburns as a risk factor for BCC (17) . In order to determine a possible gene-environment interaction, the lifetime number of sunburns was correlated to the genotype and BCC. genotypes and the number of lifetime sunburns in this study No interaction between exposure and genotypes was found for group, which might reflect that sun-exposure is difficult to any of the three polymorphisms.
assert by questionnaires. Interestingly, it appeared that a family history of nonDiscussion melanoma skin cancer influenced the genotype distributions. The allele frequencies in both the exon 6 and 10 polyThis investigation reiterates that the silent polymorphism in morphisms seemed to be different in BCC cases with and codon 156 of exon 6 influences the risk of developing BCC.
without family history of non-melanoma skin cancer (Table The C-allele seems to be protective. We also found suggestions VI). The protective influence of exon 6 C was exclusively of an association between the codon 312 polymorphism in present in the persons without a family history of skin exon 10 and risk of BCC among subjects with a family history cancer. Conversely, the protective influence of exon 10 G was of non-melanoma skin cancer. No statistically significant effect exclusively present among the subjects with a family history of the exon 23 polymorphism was found, indicating that the of skin cancer. The fact that the two factors are not additive polymorphism may not be associated with risk of BCC.
could suggest that family history overrides the importance of Recently, diverging results have been published as to which the exon 6 polymorphism. However, the two polymorphisms allele is protective in the exon 23 polymorphism. The exon are genetically tightly linked, and the protective exon 6 C allele 23 C allele was found to be marginally associated with increased co-segregates with the risk allele exon 10 A (Table VII) . Thus, risk of cancer of the neck and head (15). On the other hand, the two linked alleles have opposite effects, so we would only the exon 23 A allele has been shown to be associated with see the effect of one of the protective alleles at a time. This suboptimal DNA repair activity (X-ray induced chromatid may explain why the allele frequency of the protective exon aberrations) (12) , and to risk of BCC and the age of onset of 6 C allele is higher among subjects with a family history of BCC (11) .
non-melanoma skin cancer than among subjects without a The exon 6 polymorphism does not result in an amino acid family history of non-melanoma skin cancer, even though change. It is therefore unlikely that the enzymatic function of family history of skin cancer is a risk factor for BCC (Table VI) . XPD is affected by the mutation. The mutation may influence In summary, our results indicate that exon 6 A is a risk factor the rate of translation by altering codon usage or reduce XPD for BCC. protein levels through an effect on mRNA stability (11) . Alternatively, the exon 6 polymorphism may be linked to
